Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Highly Sensitive Molecular Test Developed for Tuberculosis

By LabMedica International staff writers
Posted on 15 Sep 2014
Rapid, accurate detection of Mycobacterium tuberculosis is crucial in the diagnosis of tuberculosis (TB), but conventional diagnostic methods have limited sensitivity and specificity or are time consuming.

A new highly sensitive nucleic acid amplification (NAA) test, combined nested and real-time polymerase chain reaction (PCR) in a single tube, one-tube nested real-time PCR, was developed for detecting M. More...
tuberculosis, which takes advantages of two PCR techniques, including real-time PCR.

Biomedical Laboratory Scientists at Yonsei University (Wonju, Republic of Korea) and their colleagues collected sputum specimens from 167 subjects having active TB and from 108 healthy subjects. Sputum specimens were liquefied and processed and the sediment were suspended in sterile saline and used for smear preparation, inoculation into Löwenstein-Jensen (LJ) media and DNA extraction. The presence of acid fast bacilli (AFB) was examined using a light microscope and the results of AFB smear were graded.

Initial identification of M. tuberculosis was confirmed using the SD TB Ag MPT64 immunochromatographic test (SD Bioline Inc.; Yongin, Korea) and the REBA Myco-ID molecular diagnostic kit (M&D Inc.; Wonju, Korea). The scientists designed a one-tube nested real-time PCR to have two sequential reactions with two sets of primers and dual probes for the IS6110 sequence of M. tuberculosis in a single closed tube. A real-time PCR assays were performed and validated using an Applied Biosystems 7500 Fast Real-time PCR System (Foster City, CA, USA).

The minimum limits of detection of IS6110 real-time PCR was 100 fg/μL and for the IS6110 one-tube nested real-time PCR it was 1 fg/μL of M. tuberculosis DNA. AdvanSure TB/NTM real-time PCR (LG Life Science; Seoul, Korea), IS6110 real-time PCR, and one-tube nested real-time PCR showed 100% sensitivity and 100% specificity for clinical M. tuberculosis isolates and nontuberculous mycobacteria (NTM) isolates. In comparison, the sensitivities of AdvanSure TB/NTM real-time PCR was 91% (152/167), 94.6% (158/167) for the single IS6110 real-time PCR, and 100% (167/167) one-tube nested real-time PCR.

The authors concluded that the new efficient, highly sensitive PCR assay, one-tube nested real-time PCR targeting IS6110 sequence that was developed for detecting M. tuberculosis, utilizes the advantages of nested PCR and real-time PCR. One-tube nested real-time PCR showed superior sensitivity to conventional real-time PCR and AdvanSure TB/NTM real-time PCR, a commercial TB real-time PCR kit. The study was published on August 30, 2014, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Yonsei University 
SD Bioline Inc.
M&D Inc.




Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.